YU25096A - Inhibicija fotodekompozicije 3-supstituisanog-2-oksindola - Google Patents

Inhibicija fotodekompozicije 3-supstituisanog-2-oksindola

Info

Publication number
YU25096A
YU25096A YU25096A YU25096A YU25096A YU 25096 A YU25096 A YU 25096A YU 25096 A YU25096 A YU 25096A YU 25096 A YU25096 A YU 25096A YU 25096 A YU25096 A YU 25096A
Authority
YU
Yugoslavia
Prior art keywords
substituted
oxindoles
photodecomposition
inhibiting
inhibiting photodecomposition
Prior art date
Application number
YU25096A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Willard Newlin
Sharon Laughlin
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of YU25096A publication Critical patent/YU25096A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Polymerisation Methods In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
YU25096A 1995-04-24 1996-04-23 Inhibicija fotodekompozicije 3-supstituisanog-2-oksindola YU25096A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (fr) 1995-04-24 1995-04-24 Inhibition de la photodecomposition des 2-oxindoles-3-substitues

Publications (1)

Publication Number Publication Date
YU25096A true YU25096A (sh) 1998-08-14

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
YU25096A YU25096A (sh) 1995-04-24 1996-04-23 Inhibicija fotodekompozicije 3-supstituisanog-2-oksindola

Country Status (30)

Country Link
EP (1) EP0827399A1 (fr)
JP (1) JPH10506635A (fr)
KR (1) KR100189585B1 (fr)
CN (1) CN1053667C (fr)
AP (1) AP607A (fr)
AR (1) AR002728A1 (fr)
AU (1) AU692378B2 (fr)
BG (1) BG100531A (fr)
BR (1) BR9602024A (fr)
CO (1) CO4700418A1 (fr)
FI (1) FI973988A0 (fr)
HR (1) HRP960194A2 (fr)
HU (1) HU216544B (fr)
IL (1) IL117969A0 (fr)
IS (1) IS4339A (fr)
MA (1) MA23848A1 (fr)
NO (1) NO961622L (fr)
NZ (1) NZ286432A (fr)
OA (1) OA10286A (fr)
PE (1) PE34397A1 (fr)
RO (1) RO113305B1 (fr)
RU (1) RU2109510C1 (fr)
SG (1) SG64924A1 (fr)
SI (1) SI9600133A (fr)
SK (1) SK51296A3 (fr)
TR (1) TR199600300A2 (fr)
UA (1) UA42739C2 (fr)
WO (1) WO1996033701A1 (fr)
YU (1) YU25096A (fr)
ZA (1) ZA963210B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019132959A1 (fr) 2017-12-29 2019-07-04 Kraft Foods Group Brands Llc Stabilité oxydative améliorée d'émulsions huile dans eau à l'aide de stabilisants naturels

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
AP607A (en) 1997-08-27
UA42739C2 (uk) 2001-11-15
SK51296A3 (en) 1997-04-09
FI973988A (fi) 1997-10-17
HRP960194A2 (en) 1998-02-28
IL117969A0 (en) 1996-08-04
WO1996033701A1 (fr) 1996-10-31
NO961622D0 (no) 1996-04-23
BR9602024A (pt) 1998-10-06
EP0827399A1 (fr) 1998-03-11
NZ286432A (en) 1998-05-27
RU2109510C1 (ru) 1998-04-27
NO961622L (no) 1996-10-25
RO113305B1 (ro) 1998-06-30
AR002728A1 (es) 1998-04-29
HU9601057D0 (en) 1996-06-28
IS4339A (is) 1996-10-25
AP9600787A0 (en) 1996-04-30
SI9600133A (en) 1996-10-31
AU692378B2 (en) 1998-06-04
HUP9601057A2 (en) 1997-04-28
CN1139110A (zh) 1997-01-01
MA23848A1 (fr) 1996-12-31
CO4700418A1 (es) 1998-12-29
AU5085196A (en) 1996-11-07
KR960037656A (ko) 1996-11-19
FI973988A0 (fi) 1997-10-17
TR199600300A2 (tr) 1996-11-21
OA10286A (en) 1997-09-19
CN1053667C (zh) 2000-06-21
BG100531A (en) 1997-06-30
SG64924A1 (en) 1999-05-25
JPH10506635A (ja) 1998-06-30
HUP9601057A3 (en) 1997-05-28
ZA963210B (en) 1997-10-23
HU216544B (hu) 1999-07-28
PE34397A1 (es) 1997-09-29
KR100189585B1 (ko) 1999-06-01

Similar Documents

Publication Publication Date Title
YU35697A (en) Substituted 6,6-hetero-bicyclic derivatives
DE69613985D1 (de) Meta-guanidine, harnstoff, thioharnstoff oder azacyklische aminobenzoesäure-derivate als integrin antagonisten
RS49531B (sr) Estrogen agonisti/antagonisti
ID27652A (id) Turunan amida yang digunakan sebagai inhibitor produksi sitokina
ES2163407T3 (es) Derivados piperidinilos tiaciclicos.
DE59709414D1 (de) Oxyiminopregnancarbolactone
AR038429A2 (es) Compuestos 15-alquil-16-hidroxilo de marcfortina
RS50140B (sr) Postupak za dobijanje perkihinina i njegova upotreba
SE9504661D0 (sv) New compounds
ME00384B (fr) Composes contenant du lactame et leurs derives en tant qu'inhibiteurs du facteur xa
KR950701911A (ko) 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제(peripheral vaso-dilating agent containing piperidine derivative as active ingredient)
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
FI970150A (fi) Substituoituja pyrimidiiniyhdisteitä ja niiden käyttö
ES2158327T3 (es) Derivados de benzo(g)quinolina.
YU17301A (sh) KRISTALNI OBLICI EtO2C-CH2-(R)-Cgl-Aze-Pab-OH
YU30603A (sh) Derivati premošćenog piperazina
PT696194E (pt) Utilizacao de derivados de indole como antagonistas de 5ht1
CA2356985A1 (fr) Antagonistes du recepteur 5ht1 pour therapie antidepressive
CO4340625A1 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos
YU25096A (sh) Inhibicija fotodekompozicije 3-supstituisanog-2-oksindola
SE9504662D0 (sv) New compounds
DE69330601D1 (de) Serotoninergische ergolin derivate
WO2001010848A3 (fr) Inhibiteurs de tryptase
CA2032797A1 (fr) Composes antithrombotiques
RS50449B (sr) Supstituisani bisindolilmaleimidi za inhibiciju proliferacije ćelija